» Articles » PMID: 7097866

RNA Synthesis by Newcastle Disease Virus Temperature-sensitive Mutants in Two RNA-negative Complementation Groups

Overview
Journal J Virol
Date 1982 Jun 1
PMID 7097866
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The temperature-sensitive RNA-negative mutants of Newcastle disease virus comprise two complementation groups, group A (seven members) and group E (one member). The RNA-synthesizing activities of four representative members of group A and the single member of group E were compared with the activity of the wild type. These mutants were defective to varying extents in primary transcription at the nonpermissive temperature, ranging from mutant A1, which had no activity, to mutant E1, which lost only 50% of its activity. All of the mutants were also defective in a postprimary transcriptive process since after preincubation at the permissive temperature in the presence of cycloheximide, there was no subsequent RNA synthesis at the nonpermissive temperature upon removal of the cycloheximide. Similarly, in experiments in which cycloheximide was not used, shifts from the permissive temperature to the nonpermissive temperature before 3 h postinfection did not result in RNA synthesis. However, later shifts to the nonpermissive temperature did allow RNA synthesis. With the exception of mutant A1, all of the mutants maintained this RNA-synthetic ability for at least 3 h, suggesting that RNA synthesis from progeny genomes was not the major postprimary transcriptive defect in these mutants. In contrast, the RNA-synthetic ability of mutant A1 rapidly decayed at the nonpermissive temperature, suggesting that the A gene product is involved in RNA synthesis from progeny genomes. The postprimary transcriptive defect(s) of the other mutants may be in the processing or stability of a protein, in the processing of mRNA, or in replication. Plaque-forming revertants (ts+) of all of the mutants coreverted for RNA synthesis. This finding strengthens the relationship between temperature sensitivity for plaquing and both the primary and postprimary RNA-negative phenotypes.

Citing Articles

Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.

Ray R, Galinski M, Heminway B, Meyer K, Newman F, Belshe R J Virol. 1996; 70(1):580-4.

PMID: 8523574 PMC: 189848. DOI: 10.1128/JVI.70.1.580-584.1996.


Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

Ray R, Meyer K, Newman F, Belshe R J Virol. 1995; 69(3):1959-63.

PMID: 7853542 PMC: 188817. DOI: 10.1128/JVI.69.3.1959-1963.1995.


Thermostabilities of virion activities of Newcastle disease virus: evidence that the temperature-sensitive mutants in complementation groups B, BC, and C have altered HN proteins.

Peeples M, Glickman R, Bratt M J Virol. 1983; 45(1):18-26.

PMID: 6823010 PMC: 256382. DOI: 10.1128/JVI.45.1.18-26.1983.

References
1.
GHARPURE M, Wright P, Chanock R . Temperature-sensitive mutants of respiratory syncytial virus. J Virol. 1969; 3(4):414-21. PMC: 375786. DOI: 10.1128/JVI.3.4.414-421.1969. View

2.
Bratt M, Gallaher W . Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci U S A. 1969; 64(2):536-43. PMC: 223377. DOI: 10.1073/pnas.64.2.536. View

3.
Pringle C . Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate. J Virol. 1970; 5(5):559-67. PMC: 376041. DOI: 10.1128/JVI.5.5.559-567.1970. View

4.
Pringle C, Duncan I . Preliminary physiological characterization of temperature-sensitive mutants of vesicular stomatitis virus. J Virol. 1971; 8(1):56-61. PMC: 356213. DOI: 10.1128/JVI.8.1.56-61.1971. View

5.
East J, Kingsbury D . Mumps virus replication in chick embryo lung cells: properties of ribonucleic acids in virions and infected cells. J Virol. 1971; 8(2):161-73. PMC: 356227. DOI: 10.1128/JVI.8.2.161-173.1971. View